Dutasteride

How does dutasteride work?

Like finasteride, dutasteride belongs to the 5-alpha-reductase inhibitors. This group of ingredients reduces the conversion of testosterone to dihydrotestosterone (DHT), which plays a central role in androgenetic alopecia. DHT contributes to sensitive hair follicles shrinking over the years and producing finer hairs.

The difference lies in the enzyme profile. Finasteride mainly inhibits type II 5-alpha-reductase, dutasteride inhibits types I and II. ^[1] A second difference is how long it stays in the body. Dutasteride has a half-life of three to five weeks. After stopping, it takes around four months for DHT levels to return to baseline. ^[5] Both points matter for the medical assessment, because a broader and longer-lasting effect on hormone metabolism is not automatically the better fit. The page on finasteride describes how finasteride itself works and how it has been studied.

Key facts and figures

The figures below come from the studies listed at the end of this page and from the Swiss prescribing information. They describe study groups and do not predict the result for any one person.

• In a randomised trial, 416 men aged 21 to 45 received different doses of dutasteride, finasteride or placebo for 24 weeks. Hair count rose with dutasteride compared with placebo, depending on the dose. ^[1]
• A second trial with 917 men aged 20 to 50 compared dutasteride 0.5 mg, finasteride 1 mg and placebo over 24 weeks. Hair count and hair width rose with dutasteride compared with placebo, and the number and severity of adverse events were similar between groups. ^[2]
• A meta-analysis comparing dutasteride with finasteride is based on only three trials with 576 participants and a duration of 24 weeks. There was no significant difference between the two ingredients in libido, erection or ejaculation. ^[3]
• In a meta-analysis of placebo-controlled trials, the relative risk of sexual dysfunction with dutasteride 0.5 mg was 1.37. The increase was not statistically significant, but the data are limited. ^[4]
• Dutasteride has a half-life of three to five weeks. ^[5]
• In Switzerland, dutasteride 0.5 mg is authorised for the treatment of benign prostatic hyperplasia and belongs to supply category B. ^{[5] [7] [8]}

What the studies show

Dutasteride has been studied in randomised trials in men with androgenetic alopecia. Compared with placebo, effects on hair count and density were seen. ^{[1] [2]} There are also direct comparisons with finasteride and a systematic review of them, but their evidential value is limited. ^[3]

These data have limits that belong in any interpretation. The comparative trials ran for 24 weeks, much shorter than the multi-year trials of finasteride. The review is based on only three comparative trials. ^[3] Long-term data come mainly from studies in prostate enlargement, that is, from a different group of a different age. ^[5] Results from short trials therefore say nothing about whether dutasteride suits a particular person. Weighing benefit, risk and personal situation is exactly the core of the medical assessment.

Oral and topical forms

Dutasteride is studied and authorised as a soft capsule taken by mouth. The capsule must not be opened or chewed, because its contents can irritate the lining of the mouth and the ingredient is absorbed through the skin. ^[5]

There is no topical dutasteride preparation authorised as a ready-made medicine. Where it exists, it is made as an individual compounded preparation, and there are far fewer studies on it than on the oral form. Even with local application, some of the ingredient can reach the body. Whether any form is justifiable in an individual case, and which one, belongs in the medical assessment. The guide on topical and oral finasteride explains the comparison of forms using finasteride as an example.

Authorisation and prescription status in Switzerland

In Switzerland, dutasteride is authorised at a strength of 0.5 mg for the treatment of benign prostatic hyperplasia, a non-cancerous enlargement of the prostate. There is no authorisation for hair loss. ^[5] In androgenetic alopecia, its use is therefore off-label. The treating physician takes responsibility for it and must weigh benefit and risk particularly carefully. The guide dutasteride in Switzerland explains where dutasteride is authorised for hair loss and what off-label use means for you.

Dutasteride requires a prescription and belongs to supply category B. ^{[7] [8]} It may only be dispensed against a medical prescription. The Swiss prescribing information is publicly available on Swissmedicinfo. It describes the effects and risks for the authorised use in prostate enlargement and is still the most important reference for contraindications, interactions and warnings. ^[5] In November 2025, the marketing authorisation holders, in agreement with Swissmedic, issued information on measures concerning the risk of suicidal thoughts with finasteride and dutasteride. ^[6]

Compounded preparations and what they mean for you

A physician can prescribe an individual preparation that a pharmacy makes for one specific person. Swiss therapeutic products law calls this a magistral formula (formula magistralis). ^[9] Such preparations do not need their own authorisation, because they are made against a specific prescription. ^[9] For dutasteride, this mainly concerns topical preparations, for which no ready-made product exists.

For you, this means such a preparation sits outside the standard in two ways. It is not authorised, and the use for hair loss is off-label anyway. There is no dedicated prescribing information, and the evidence is limited. That is why the medical justification in each individual case is particularly important, as is an honest discussion of what is known and what is not. The pharmacy is responsible for the quality of the preparation.

Availability and costs

In Switzerland, dutasteride is only available with a valid medical prescription, dispensed by a pharmacy or a self-dispensing medical practice. How long a prescription remains valid is regulated by each canton, so long-term treatment needs a new medical assessment at regular intervals. ^[10]

For hair loss, treatment is paid out of pocket. Basic insurance only covers services that treat an illness and are effective, appropriate and economical, and off-label use for hereditary hair loss generally does not qualify. ^[11] Costs are made up of the medical consultation, the product or preparation and follow-up checks, which are billed separately or included depending on the provider. The guide What does hair loss treatment cost in Switzerland gives a neutral overview of the options.

Safety

The possible side effects are similar to those of finasteride. They include sexual dysfunction, breast symptoms, skin reactions and mood symptoms. ^{[4] [5]} The Swiss prescribing information, which is based on studies in prostate enlargement, lists breast enlargement and breast tenderness as common, and allergic reactions and low mood as very rare. ^[5] For dutasteride, it is recommended to seek medical advice without delay in the event of mood changes. The evidence for a direct link with suicidal thoughts is described as insufficient. ^[6]

Because dutasteride stays in the body for a long time, particular caution is needed during pregnancy or possible contact with pregnant women, especially with leaking capsules. ^[5] Plans to have children, liver disease, other medication, PSA as a lab value and previous side effects with DHT inhibitors are also part of the medical assessment.

Reference page and guides

This page is a reference. It describes what dutasteride is, what the studies show, which risks are known and what its status is in Switzerland. It does not say whether dutasteride is right for you, and it contains no dosing recommendation. The doses listed above reflect what is described in the authorisation and in the literature.

Dutasteride is not a variant of finasteride but an ingredient in its own right, with its own risk profile. The guide finasteride prescription in Switzerland explains how physician-guided treatment with DHT inhibitors works, and the guide to side effects covers the benefit-risk assessment for this group. At orva, licensed Swiss physicians review your answers to a medical questionnaire and decide whether treatment is medically appropriate.

With orva, you can treat hair loss online in Switzerland. You start with a medical questionnaire. Licensed Swiss physicians review your information. If medically appropriate, the physician may issue a prescription.